Article Versions Notes

Ji D, Ma J, Dai J, Xu M, Harris PWR, Brimble MA, Agyei D. Anticholinesterase Inhibition, Drug-Likeness Assessment, and Molecular Docking Evaluation of Milk Protein-Derived Opioid Peptides for the Control of Alzheimer’s Disease. Dairy. 2022; 3(3):422-437. https://doi.org/10.3390/dairy3030032

Ji, Dawei, Jingying Ma, Junyi Dai, Min Xu, Paul W. R. Harris, Margaret A. Brimble, and Dominic Agyei. 2022. "Anticholinesterase Inhibition, Drug-Likeness Assessment, and Molecular Docking Evaluation of Milk Protein-Derived Opioid Peptides for the Control of Alzheimer’s Disease" Dairy 3, no. 3: 422-437. https://doi.org/10.3390/dairy3030032

Ji, D., Ma, J., Dai, J., Xu, M., Harris, P. W. R., Brimble, M. A., & Agyei, D. (2022). Anticholinesterase Inhibition, Drug-Likeness Assessment, and Molecular Docking Evaluation of Milk Protein-Derived Opioid Peptides for the Control of Alzheimer’s Disease. Dairy, 3(3), 422-437. https://doi.org/10.3390/dairy3030032